The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies.
- DOI
- 10.1186/s43046-026-00389-0
- Published
- 2026 Jul 27
- Container
- Journal of the Egyptian National Cancer Institute
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s43046-026-00389-0,
title = {The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies.},
author = {Faradina D and Rusda M and Siregar MFG and Adella CA and Putra A and Prananda AT and Suardi D and Marpaung J and Khosasi F},
year = {2026},
journal = {Journal of the Egyptian National Cancer Institute},
doi = {10.1186/s43046-026-00389-0},
url = {https://doi.org/10.1186/s43046-026-00389-0}
}RIS
TY - JOUR TI - The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies. AU - Faradina D AU - Rusda M AU - Siregar MFG AU - Adella CA AU - Putra A AU - Prananda AT AU - Suardi D AU - Marpaung J AU - Khosasi F PY - 2026 JO - Journal of the Egyptian National Cancer Institute DO - 10.1186/s43046-026-00389-0 UR - https://doi.org/10.1186/s43046-026-00389-0 ER -
APA
D, F., M, R., MFG, S., CA, A., A, P., AT, P., D, S., J, M., & F, K. (2026). The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies.. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1186/s43046-026-00389-0
Source records
- pubmed · retrieved 2026-09-26T18:52:44.697Z